ConductScience.org, home

Trial · NCT02909400

Registered outcomes25

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMovement disordersone monthRater assessed change from baseline of motoric abnormalities and movement characteristics
SecondaryNMDASone monthChange from baseline of the Newcastle Mitochondrial Disease Activity Score
SecondarySpirometric parameters (FVC,FEV1, PEF)one monthChange from baseline in spirometric parameters
SecondarySpirometric parameters (MIP, MEP)one monthChange from baseline in spirometric parameters
SecondarySit to Stand Test (30 seconds)one monthChange from baseline assessment of the maximum number of sit-standings in 30 seconds time
SecondaryHandgrip Dynamometryone monthChange from baseline assessment of the maximum grip strenght
Secondary6-min chewing testone monthChange from baseline assessment in rate of mastication
Secondary6-min chewing testone monthChange from baseline assessment of pain and tiredness (VAS) during a 6-min chewing test
Secondary6-MWTone monthChange from baseline assessment of the Distance during a 6-min Walk Test
SecondaryRAND-SF36 scoreone monthChange from baseline in the RAND-SF36
SecondaryHAD and BDIone monthChange from baseline in the Hospital Anxiety and Depression Scale (HAD), supplemented with a Beck Depression Index (BDI)
SecondaryBDIone monthChange from baseline in the Beck Depression Index (BDI)
SecondaryCISone monthChange from baseline in the Checklist Individual Strength
SecondaryTAPone monthChange from baseline assessment of alertness and mental flexibility during a Test of Attentional Performance (TAP)
SecondaryGoal Attainment Scaleone monthAssessment of pre-defined goal attainment during each treatment period
SecondaryRegistration of Motor Activity and Sleeping patternone monthDuring each treatment period a continuous registration of Motor Activity and Sleeping pattern by accelerometer, assessing sleep quality, quantity and overall motor activity
SecondaryVital Signsone monthChange from Baseline assessment of vital signs (heart rate, blood pressure)
SecondaryECGone monthChange from Baseline assessment of ECG-intervals
SecondaryClinical Laboratoryone monthChange from Baseline assessment of Clinical Laboratory parameters
SecondaryPharmacokinetics of KH176 and metabolitesone monthAttainment of steady state and total exposure (AUC) at steady state conditions

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02909400/registered